BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging & Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250425T133000
DTEND;TZID=Europe/Vienna:20250425T143000
DTSTAMP:20260421T102542
CREATED:20241017T081307Z
LAST-MODIFIED:20250214T105155Z
UID:1936-1745587800-1745591400@esmit.eanm.org
SUMMARY:Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging (pre-recorded)
DESCRIPTION:more information coming soon \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/highlights-of-focus-meeting-6-shaping-the-future-of-breast-cancer-care-with-molecular-imaging-prerecorded/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250404T133000
DTEND;TZID=Europe/Vienna:20250404T143000
DTSTAMP:20260421T102542
CREATED:20241017T080415Z
LAST-MODIFIED:20250326T095143Z
UID:1928-1743773400-1743777000@esmit.eanm.org
SUMMARY:Radioiodine-Refractory Thyroid Cancer - Is it Time to Change the Definition in the Light of Novel Redifferentiation Therapies?
DESCRIPTION:This webinar explores the perspectives on radiorefractory thyroid cancer through two presentations. In the first talk the speaker challenges current diagnostic frameworks and proposes a new vision that better reflects the evolving understanding of refractory thyroid cancer. The second presentation offers a comprehensive review of emerging approaches to restore iodine avidity in radiorefractory thyroid cancer\, highlighting recent clinical trials\, molecular targeting techniques\, and potential promising combination therapies. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo evaluate the current definition of radiorefractory thyroid cancer and identify its limitations in clinical practice\n\n\n\nTo learn new insights for radiorefractory thyroid cancer definition and their potential impact on treatment decisions\n\n\n\nTo learn current evidence-based redifferentiation strategies for restoring iodine avidity in radiorefractory thyroid cancer\n\n\n\nTo improve knowledge of redifferentiation mechanisms to develop personalized treatment plans for patients with radiorefractory thyroid cancer\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear Medicine physicians\, Endocrinologist\, Oncologist \n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nPetra PetranovicSpeaker \n\n\n\n\n\nMichael KreisslSpeaker \n\n\n\n\n\nLuca GiovanellaModerator \n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/radioiodine-refractory-thyroid-cancer-is-it-time-to-change-the-definition-in-the-light-of-novel-redifferentiation-therapies/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250320T090000
DTEND;TZID=Europe/Vienna:20250321T160000
DTSTAMP:20260421T102542
CREATED:20241017T082921Z
LAST-MODIFIED:20250314T130204Z
UID:1951-1742461200-1742572800@esmit.eanm.org
SUMMARY:Cardiac Amyloidosis Imaging: History\, Status Quo and Outlook
DESCRIPTION:This course provides a comprehensive overview of the multimodality diagnosis of cardiac amyloidosis. Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore\, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. Imaging modalities will include a focus on echocardiography\, cardiac MRI\, SPECT\, and PET\, with discussion of the various tracers available. It will be elaborated when which of the different imaging modalities can be used appropriately and multimodality concepts will also be discussed. The course content will be developed using numerous case examples. Furthermore\, the course participants should solve cases independently and discuss them with the other course participants. \n\n\n\n\n\n\n\nRegister nowRegistrations are closed. Please contact us at esmit@eanm.org if you are still interested in signing up for the course. \n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nGain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nGain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nBecome familiar with the various imaging modalities available for the diagnosis of cardiac amyloidosis.\n\n\n\nTo learn the appropriate use of diagnostic options in cardiac amyloidosis (keyword: diagnostic algorithm).\n\n\n\nTo independently make the correct diagnosis of cardiac amyloidosis on the basis of case studies.\n\n\n\nTo learn the possibilities of quantification of SPECT and PET.\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nNuclear physicians\, cardiologists\, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics.\n\n\n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nStephan NekollaSpeakerMunich\, Germany \n\n\n\n\n\nRaffaella CalabrettaSpeakerVienna\, Austria \n\n\n\n\n\nCarmela NappiSpeakerNaples\,Italy \n\n\n\n\n\nDietrich BeitzkeSpeakerVienna\,Austria \n\n\n\n\nMichael PoledniczekSpeakerVienna\,Austria \n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/cardiac-amyloidosis-imaging-history-status-quo-and-outlook/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250221T133000
DTEND;TZID=Europe/Vienna:20250221T143000
DTSTAMP:20260421T102542
CREATED:20241017T075932Z
LAST-MODIFIED:20250217T121048Z
UID:1922-1740144600-1740148200@esmit.eanm.org
SUMMARY:Surgery in Neuroendocrine Neoplasms (NENs)
DESCRIPTION:Neuroendocrine tumours (NETs) are a rare but clinically significant group of malignancies arising from neuroendocrine cells\, often presenting in the gastrointestinal tract or lungs. While NETs account for a small fraction of overall cancer cases\, their incidence is steadily rising. Radioguided surgery has emerged as a highly effective approach for treating NETs\, particularly in cases of primary tumours or oligometastatic disease\, where nuclear medicine imaging precisely localizes the lesions and surgical resection is feasible. \n\n\n\nThis session will explore the current landscape of radioguided surgery\, with a specific focus onneuroendocrine tumour applications. We will begin by reviewing the latest tracers and instrumentation employed in radioguided procedures\, discussing their mechanisms\, advantages\, and limitations. Following this\, we will delve into the clinical integration of these tracers and devices\, examining their role in the routine surgical workflow for NETs. By highlighting the practical implications and clinical outcomes\, this session aims to provide attendees with actionable insights into advancing care for patients with neuroendocrine tumours. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nAttendees will be able to describe the latest advancements in radiotracers and surgical instrumentation for radioguided neuroendocrine tumour surgery\, including their mechanisms of action and clinical benefits. \n\n\n\nAttendees will be able to evaluate the indications for radioguided surgery in neuroendocrine tumours\, such as primary tumours and oligometastatic disease\, based on pre-operative nuclear medicine imaging. \n\n\n\nAttendees will be able to outline the steps required to integrate novel radiotracers and devices into the clinical workflow\, from surgical planning to intraoperative application\, with a focus on improving patient outcomes.\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nSurgical oncologists\, nuclear medical physicians\, medical physicists\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nThomas WendlerModerator \n\n\n\n\n\nPedro Fragoso Costa Speaker \n\n\n\n\n\nJohn Orozco CortesSpeaker \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/surgery-in-neuroendocrine-neoplasms-nens/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250207T133000
DTEND;TZID=Europe/Vienna:20250207T143000
DTSTAMP:20260421T102542
CREATED:20241017T075631Z
LAST-MODIFIED:20250203T100308Z
UID:1920-1738935000-1738938600@esmit.eanm.org
SUMMARY:Bone Scan Beyond Oncological Disease
DESCRIPTION:The webinar primarily focuses on the clinical value and implementation of early phase SPECT-CT in non-oncological settings\, emphasizing its advantages over traditional planar imaging and late-phase bone scans. It highlights the diagnostic enhancement of early-phase imaging for inflammatory conditions\, pain assessment\, and soft-tissue evaluation. \n\n\n\nNew treatment options for cardiac amyloidosis are increasing interest in early diagnosis of the disease. DPD scan is an excellent and non-invasive diagnostic modality in this diagnosis\, but detailed local\, whole body and SPECT/CT including calculation of different ratios are necessary for an accurate diagnosis. The presentation showed the performance of the examination\, clinical and medical letter examples.  \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nJules Zhang-YinSpeakerArlon\, Belgium \n\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/bone-scan-beyond-oncological-disease/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241212T090000
DTEND;TZID=Europe/Vienna:20241213T120000
DTSTAMP:20260421T102542
CREATED:20240213T182114Z
LAST-MODIFIED:20250116T094547Z
UID:1247-1733994000-1734091200@esmit.eanm.org
SUMMARY:Algorithms for Dementia Imaging
DESCRIPTION:UEMS EACCME has granted the accreditation of 7 CME credits for this event. \n\n\n\nThe course will offer a comprehensive overview of basic\, theoretical and practical evidence-based concepts needed for a deep and thoughtful understanding of the use of [¹⁸F]FDG (FDG) Brain PET\, amyloid (Amy) PET and DaT SPECT in Neurological Disorders. A brief introduction will be given on the position that each imaging technique holds in the recent European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. Then\, short theoretical sessions on visual reading and semiquantification of FDG PET\, Amy PET and DaT SPECT will be associated with longer hands-on sessions\, for a practice-oriented learning specifically addressed to dementing disorders and neurodegenerative parkinsonian syndromes. Different approaches for semiquantification and subsequent scan reporting will be proposed and discussed. Clinical cases will be the starting point to better define the usefulness\, utility and accurate reading of PET and SPECT in Alzheimer’s disease\, other neurodegenerative dementias and Parkinsonian Syndrome.n coming soon \n\n\n\n\n\n\n\nSave yourself a seatRegistration closed. For last minute registration\, please email us at esmit@eanm.org Register now!\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nTo familiarise with the neuroimaging tools available to objectively assess brain glucose metabolism\, amyloid deposition and dopaminergic system integrity\, and their position in recent European recommendations \n\n\n\nTo learn strengths and weaknesses of different approaches for semiquantification \n\n\n\nTo appropriately choose a semi-quantitative support for image interpretation in various conditions\n\n\n\nThe course will provide important information on the most recent developments for an improved clinical practice\, of utmost importance for nuclear medicine physicians.\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nGeneral nuclear medicine specialists\, radiologists who want to update their knowledge on reading\, semiquantification and reporting of FDG PET\, Amy PET and DaT SPECT in terms of clinical indications\, reading skills and pitfalls. The constantly evolving role of Brain PET in neurodegenerative disorders makes the track of interest also for neurologists who want to improve their knowledge of cutting-edge Neuroimaging tools.\n\n\n\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nValentina BertiSpeakerFlorence\, Italy \n\n\n\n\n\nIgor YakushevSpeakerMunich\, Germany \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/algorhythms-for-dementia-imaging/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241206T133000
DTEND;TZID=Europe/Vienna:20241206T143000
DTSTAMP:20260421T102542
CREATED:20240213T193126Z
LAST-MODIFIED:20241203T102334Z
UID:1300-1733491800-1733495400@esmit.eanm.org
SUMMARY:Treatment of Metastatic Bone Pain Using Bone-Seeking Agents
DESCRIPTION:With the arrival of new therapeutic tracers\, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of nuclear medicine among other treatment modalities (external beam therapy\, medical treatment\, chemotherapy). \n\n\n\nLearning Objectives: Refresh knowledge on the pathophysiology of pain and present the opportunities and limitations of alpha and beta therapy in metastatic bone pain treatment \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nJules Zhang-YinModeratorArlon\, Belgium \n\n\n\n\n\n\n\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\n\nTatiana LouroSpeakerLisbon\, Portugal \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/treatment-of-metastatic-bone-pain-using-bone-seeking-agents-msk/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241202T100000
DTEND;TZID=Europe/Vienna:20241202T110000
DTSTAMP:20260421T102542
CREATED:20240702T080051Z
LAST-MODIFIED:20241119T122958Z
UID:1737-1733133600-1733137200@esmit.eanm.org
SUMMARY:Japanese vs. European View on Amyloid Imaging and Therapy (in collaboration with JSNM)
DESCRIPTION:The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However\, due to differences in clinical processes and insurance systems in each country\, the use of amyloid PET in the diagnostic tree currently varies from country to country. In Europe\, CSF diagnosis is often performed first and amyloid PET is performed in selected patients. In Japan\, only either CSF diagnosis or amyloid PET is covered by public insurance\, so there is a trend toward performing the more expensive PET first. The use of amyloid PET in the setting of anti-AB therapy monitoring\, and its exact positioning in the biomarkers  flow-chart is not yet clearly defined. This webinar will present recent findings on the usefulness of amyloid PET and the differences in actual use between Europe and Japan. \n\n\n\nLearning Objectives: tba \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDonatienne Van WeehaegheModerator \n\n\n\n\n\n\n\n\n\n\n\nProf. Dr. med. Dr. biol. hum. Matthias Brendel\, MHBASpeakerDepartment leadBoard certified Nuclear Medicine physician Research lead for neurodegenerative disorders LMU Klinikum   Department of Nuclear MedicineUniversity Hospital of Munich \n\n\n\n\n\nDr. Kenji IshiiSpeakerDirectorDiagnostic Neuroimaging ResearchTokyo Metropolitan Institute for Geriatrics and GerontologyTokyo\, Japan \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/japanese-vs-european-view-on-amyloid-imaging-and-therapy-in-collaboration-with-jsnm/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241114T080000
DTEND;TZID=Europe/Vienna:20241115T170000
DTSTAMP:20260421T102542
CREATED:20240213T181944Z
LAST-MODIFIED:20241031T131739Z
UID:1243-1731571200-1731690000@esmit.eanm.org
SUMMARY:Focus on Molecular-guided Surgery
DESCRIPTION:An application has been submitted to the UEMS EACCME for CME accreditation. \n\n\n\nThe course has a hybrid format with on-site lectures and hands-on practical and technic sessions\, It will cover the basic and some advanced and future aspects of Radioguided surgery with a focus on the technologist’s work and support the multidisciplinary team in charge of Radioguided procedures.   \n\n\n\n\n\n\n\nSave yourself a seatRegistration closed. For last-minute sign up please contact esmit@eanm.org \n\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nThis course aims to spread information and practice to technologist\, nurses\, medical staff (nuclear medicine\, surgeons\, radiologist)  in order to provide an interactive setting to share ideas and refine current and future approaches in the field of Radioguided Surgery\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nTo Define the radioguided surgery principles\, applications\, methodology. \n\n\n\nOverview the current state of the art of the radioguided surgery. \n\n\n\nList the clinical indications of introducing radioguided surgery to the patients. \n\n\n\nExplain the paper of a multidisciplinary team in the context of radioguided surgery. \n\n\n\nProtocols and methodologies of conventional NM exams used in radioguided surgery \n\n\n\nConventional nuclear medicine in the context of radioguided surgery: best practice\, radiation protection and safety\, organisation and patient management. \n\n\n\nTo provide the potential benefits of new technologies like IA and future perspectives.\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the Preliminary Programme. Please note\, that it may be subject to change at any time. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSergi Vidal-SicartSpeaker \n\n\n\n\n\nChiara Maria GranaSpeaker \n\n\n\n\n\nRenato Valdés OlmosSpeaker \n\n\n\n\n\nJohn OrozcoSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 863.64 \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/focus-on-molecular-guided-surgery/
LOCATION:Hospital Clínico de Barcelona\, Carrer de Villarroel\, 170\, L'Eixample\, Barcelona\, 08036\, Spain
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240920T133000
DTEND;TZID=Europe/Vienna:20240920T143000
DTSTAMP:20260421T102542
CREATED:20240213T192107Z
LAST-MODIFIED:20240731T083213Z
UID:1294-1726839000-1726842600@esmit.eanm.org
SUMMARY:Paediatric Nuclear Medicine in Nephro-Urology
DESCRIPTION:The webinar will cover the most relevant methodological aspects of nuclear medicine techniques in paediatric nephrourology\, with particular attention to the choice of the radiotracer\, the correct patient preparation\, and the acquisition protocol. Some typical cases will show the main points of image processing and results visualization. The clinical part will deal with hydronephrosis and hydroureteronephrosis\, spacing from typical pelvicureteral junction obstruction to obstructive megaureter\, and some complex malformations\, such as duplex kidneys. The selected cases will pinpoint the critical clues used in interpreting and reporting the scintigraphic studies and the integration of scintigraphic data with other imaging modalities (ultrasounds\, MRI\, etc.) in evaluating paediatric nephrourology patients. \n\n\n\nLearning Objectives: The aim of this course is to review the methodology and the main indications for scintigraphic studies in paediatric nephro-urology\, taking into accounts the more relevant and recent international guidelines and offering various examples taken from the current clinical practice. \n\n\n\nSuggested Readings:1. The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children2. EANM procedural recommendations for managing the paediatric patient diagnostic nuclear medicine \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDiego CecchinModeratorPadua\, Italy \n\n\n\n\n\nPietro ZucchettaSpeakerPadua\, Italy \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/paediatric-nuclear-medicine-in-nephro-urology/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240906T133000
DTEND;TZID=Europe/Vienna:20240906T143000
DTSTAMP:20260421T102542
CREATED:20240213T191555Z
LAST-MODIFIED:20240710T090914Z
UID:1291-1725629400-1725633000@esmit.eanm.org
SUMMARY:FDG-PET/CT in Breast Cancer
DESCRIPTION:Breast cancer is the most common cancer in women worldwide and it is still one of the leading causes of morbi-mortality\, therefore being a major concern. 2-[18F]FDG PET/CT is commonly used in the clinical management of patients with breast cancer\, with significant impact on clinical management. Currently\, there is robust evidence supporting the usefulness of 2-[18F]FDG PET/CT in the initial staging of patients with locally advanced and metastatic breast cancer\, in the early assessment of treatment response and in the early detection of recurrence. The first presentation of this webinar will summarize the recently published “Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer” which was endorsed by other relevant societies in the subject of breast cancer (ACR\, ESSO\, ESTRO\, EUSOBI/ESR\, and EUSOMA). Updated information to support the recommendations to perform 2-[18F]FDG PET/CT in no special type breast cancer in different clinical settings will be provided. Despite no special type breast cancer presenting high 2-[18F]FDG avidity\, other breast cancer subtypes seem to be better evaluated with other PET radiopharmaceuticals. Therefore\, the second presentation will address the potential role of [18F]FES\, [89Zr]Trastuzumab\, [18F]Sodium fluoride (NaF)\, [18F]Fluciclovine (FACBC)\, [89Zr]Pembrolizumab and FAPI-ligands in breast cancer. During this webinar we want to brainstorm about the role of PET/CT in the different subtypes and clinical scenarios of patients with breast cancer. The webinar will be enriched by interactive clinical case discussion\, aiming to resemble the challenges found in daily clinical practice. \n\n\n\nLearning Objectives:  \n\n\n\n\nGeneral aspects to avoid false positive and false negative findings on 2-[18F]FDG PET/CT.\n\n\n\nDiagnostic accuracy of 2-[18F]FDG PET/CT compared to conventional imaging modalities.\n\n\n\nRecommendations for performing 2-[18F]FDG PET/CT in the initial staging\, in assessing response to therapy and in assessing recurrence.\n\n\n\nAppropriate PET radiopharmaceuticals to better address each breast cancer subtype.\n\n\n\nSpecific characteristics\, physiological biodistribution\, advantages and disadvantages of PET radiopharmaceuticals used in breast cancer beyond 2-[18F]FDG.\n\n\n\nGeneral interpretation criteria to optimize the information provided in the final PET/CT report.\n\n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nLioe-Fee de Geus-OeiModeratorLeiden\, Netherlands \n\n\n\n\n\nSofia VazSpeakerLisbon\, Portugal \n\n\n\n\n\nLidija AntunovicSpeakerMilan\, Italy \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/fdg-pet-ct-in-breast-cancer/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240705T133000
DTEND;TZID=Europe/Vienna:20240705T143000
DTSTAMP:20260421T102542
CREATED:20240213T191043Z
LAST-MODIFIED:20240701T122643Z
UID:1289-1720186200-1720189800@esmit.eanm.org
SUMMARY:Guidelines for the Use of FDG PET/CT in Infection and Inflammation 2.0
DESCRIPTION:General overview of the EANM/SNMMI guidelines on FDG PET/CT in inflammation and infection. \n\n\n\nLearning Objectives: The aim of this course is to summarize the major indications for FDG PET/CT in infection and inflammation\, based on the updated guidelines for nuclear medicine practice provided by the EANM/SNMMI. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nAndor GlaudemansModeratorGroningen\, Netherlands \n\n\n\n\n\n\n\n\n\n\n\nOlivier GheysensSpeakerBrussels\, Belgium \n\n\n\n\n\nGad AbikhzerSpeakerMontreal\, Canada \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/guidelines-for-the-use-of-fdg-pet-ct-in-infection-and-inflammation-2-0/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240627T090000
DTEND;TZID=Europe/Vienna:20240628T170000
DTSTAMP:20260421T102542
CREATED:20240213T181456Z
LAST-MODIFIED:20240627T125940Z
UID:1238-1719478800-1719594000@esmit.eanm.org
SUMMARY:Role of FDG-PET in Paediatric Hodgkin and Non-Hodgkin Lymphomas
DESCRIPTION:UEMS EACCME has granted the accreditation of 8 CME credits for this event. \n\n\n\nA large oncological framework will be the topic of the first session: three lectures by a high quoted Paediatric Oncologist: epidemiology\, aetiological factors\, and general classification of Paediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies and prognostic considerations. The two valuable nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas: staging and therapeutic management\, the importance of the imaging-based assessment\, the role of Deauville classification\, prognostic aspects\, surveillance\, and the management of recurrent/treatment resistant forms in PHL and NHL. Current state of experimental tracers research. Future perspectives: novel radiotracers\, evaluation of rare entities and advanced image analysis.  \n\n\n\nMany case readings will be presented to the attendees to train them in interpreting and concluding 18FDG in the crucial assessment point into diagnostic- therapeutic PHL and NHL protocols. \n\n\n\nEach attendee is also asked to present a personal tricky case\, proposed to the experts and to the other attendees. This allows better communication among the attendees and a more interactive practical session. \n\n\n\n\n\n\n\nSave yourself a seatThe registration is closed. For last minute interest\, contact esmit@eanm.org  Register now!\n\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nResidents\, NM specialist approaching paediatric ematology-oncology\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nThe aim of this course is initially to refresh and update clinical setting from the point of view of the pediatric Oncologist: epidemiology\, aetiological factors\, and general classification of Pediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies. \n\n\n\nThe two nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas and about the importance of imaging-based assessment\, and the role of Deauville classification in the main forms of PHL and NHL.  \n\n\n\nThe current state of experimental tracers research and future perspectives: novel radiotracers\, evaluation of rare entities and advanced image analysis. Two interactive sessions with a lot of case reading to train the attendees in the evaluation\, interpretation and comparison of 18FDG-PET-CT.  \n\n\n\n\n\n\n\n\n\nProgrammeClick to view the preliminary programme View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nMarta PillonSpeakerItaly \n\n\n\n\n\nPinar KiratliSpeakerTürkiye \n\n\n\n\n\nFrancesco FizSpeakerItaly \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee Breaks on each Course Day\n\n\n\nLunch on first Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/role-of-fdg-pet-in-paediatric-hodgkin-and-non-hodgkin-lymphomas/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240614T133000
DTEND;TZID=Europe/Vienna:20240614T143000
DTSTAMP:20260421T102542
CREATED:20240213T190705Z
LAST-MODIFIED:20240611T073044Z
UID:1285-1718371800-1718375400@esmit.eanm.org
SUMMARY:Cardiovascular PET-CT and PET-MR Imaging
DESCRIPTION:Patients workflows and acquisition protocols in PET/CT and PET/MR with different radiotracers for cardiovascular nuclear medicine imaging. \n\n\n\nLearning Objectives: To learn how to manage radioactive generators 82Sr/82Rb and to acquire cardiovascular imaging in PET/CT or PET/MR and other acquisition protocols. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nPaolo TurcoModeratorPadua\, Italy \n\n\n\n\n\nStephan NekollaModeratorMunich\, Germany \n\n\n\n\n\n\nSylvia SchachoffSpeakerMunich\, Germany \n\n\n\nIan ArmstrongSpeakerManchester\, UK \n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/cardiovascular-pet-ct-and-pet-mr-imaging/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240425T090000
DTEND;TZID=Europe/Vienna:20240426T130000
DTSTAMP:20260421T102542
CREATED:20240213T173431Z
LAST-MODIFIED:20240422T130323Z
UID:1206-1714035600-1714136400@esmit.eanm.org
SUMMARY:Early Bone SPECT in Clinical Practice
DESCRIPTION:UEMS EACCME has granted the accreditation of 8.5 CME credits for this event. \n\n\n\nEarly phase SPECT has the potential to expand the diagnosis spectrum of disphosphonate scintigraphy in non-oncologic situations. Incorporated in a clinical routine\, it has the ability to focus the nuclear medicine physician attention on the most inflammatory lesions whichever they might be osseous\, para-osseous ou extra-osseous. Our 1.5 day course is intended to be a practical workshop for nuclear medicine physician interested in nuclear osteo-articular imaging\, whether they have an experience in early phase SPECT or not. It will cover the physiology of early phase physiology\, technical aspects\, interpretation guide\, most common type of lesions encountered\, with an emphasis on anatomy and CT semiology and an outlook on targeted treatment such as synoviorthesis. \n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\nHow and when to perform an early phase SPECT\n\n\n\nHow to integrate early phase\, late phase\, CT and clinical findings to elaborate a diagnosis\n\n\n\nHow to articulate our diagnosis with therapeutic tools such as synoviorthesis\, corticosteroid infiltrations and other methods\n\n\n\n\n\n\n\nNuclear medicine physician\, junior or senior\, with an interest in hybrid imaging and osteoarticular field. No experience in early phase SPECT needed.\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the Preliminary Programme. Please note\, that it may be subject to change at any time. Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nKnut LiepeSpeakerKlinikum Frankfurt (Oder)\, Germany \n\n\n\n\n\nDavid MorlandSpeakerUniversité de Reims Champagne-Ardenne\, France \n\n\n\n\n\nNicolas IcardSpeakerCentre Hospitalier de Saint Brieuc Yves Le Foll\, France \n\n\n\n\n\nJules ZhangSpeakerVivalia\, Hôpital d’Arlon\, Belgium \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee Breaks on each Course Day\n\n\n\nLunch on Day 1\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/early-bone-spect-in-clinical-practice/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240209T133000
DTEND;TZID=Europe/Vienna:20240209T143000
DTSTAMP:20260421T102542
CREATED:20240220T172054Z
LAST-MODIFIED:20240220T172055Z
UID:1465-1707485400-1707489000@esmit.eanm.org
SUMMARY:Cardiac Hybrid Imaging
DESCRIPTION:This webinar will provide knowledge about hybrid imaging SPECT/ CT and PET/CT: CT acquisition protocol\, added value of CACS and incidental findings on CTAC. \n\n\n\n \n\n\n\nLearning Objectives: The aim of the webinar is to: \n\n\n\n\nKnow about the indications for hybrid imaging in CAD \n\n\n\nDiscuss advantages and challenges \n\n\n\nGet to know the protocols \n\n\n\nKnow how to set up a hybrid imaging in your department\n\n\n\n\n\n\n\n\nWatch the recording in our Video LibraryEnter the eLearning store to register for the Annual Access Plan FOR FREE. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nFabien HyafilModeratorParis\, France \n\n\n\n\n\n\n\n\n\n\n\nFederico CaobelliSpeakerBern\, Switzerland \n\n\n\n\n\nRonny BuechelSpeakerZurich\, Switzerland \n\n\n\n\n\nAntti SarasteSpeakerTurku\, Finland \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/cardiac-hybrid-imaging/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240202T133000
DTEND;TZID=Europe/Vienna:20240202T143000
DTSTAMP:20260421T102542
CREATED:20240220T171246Z
LAST-MODIFIED:20240220T171247Z
UID:1461-1706880600-1706884200@esmit.eanm.org
SUMMARY:Diagnostic and Therapy of Medullary Thyroid Cancer
DESCRIPTION:This webinar will provide the evidence for PET imaging in medullary thyroid cancer according to the literature and the to international recommendations with a focus on the available radiopharmaceuticals and perspectives. \n\n\n\nLearning Objectives: The aim of this webinar is to understand and to learn the correct use of PET radiopharmaceuticals for staging and restaging medullary thyroid cancer. \n\n\n\n\n\n\n\nWatch the recording in our Video LibraryEnter the eLearning store to register for the Annual Access Plan FOR FREE. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDesiree DeandreisModeratorGustave Roussy – Villejuif\, France \n\n\n\n\n\n\n\n\n\n\n\nLuca GiovanellaSpeakerUniversity of Zürich – Zurich\, Switzerland \n\n\n\n\n\nJulien HadouxSpeakerENDOCAN-TUTHYREF network – Villejuif\, France \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/diagnostic-and-therapy-of-medullary-thyroid-cancer/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
END:VCALENDAR